Medicines in pregnancy: Scotland-wide cohort study protocol
- Type
- Report
- Published
- 05 November 2024
- Births and maternity
- Pharmacy and prescribing
Description
The CARDRISS and prescribing teams in Public Health Scotland are working together to develop new national data on the use of potentially teratogenic medicines in pregnancy. Potentially teratogenic medicines are those that may harm the baby when taken in pregnancy, resulting in a congenital condition or affecting the resulting child’s development. It is important that health services support pregnant women to avoid potentially teratogenic medicines in pregnancy whenever possible. Report updated with minor amendments on 3 December 2024.
The CARDRISS and prescribing teams in Public Health Scotland are working together to develop new national data on the use of potentially teratogenic medicines in pregnancy.
Potentially teratogenic medicines are those that may harm the baby when taken in pregnancy, resulting in a congenital condition or affecting the resulting child’s development.
It is important that health services support pregnant women to avoid potentially teratogenic medicines in pregnancy whenever possible.
Files
Media enquiries
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email phs.otherformats@phs.scot.
To report any issues with a publication, please email phs.generalpublications@phs.scot.